Peptides and WA Law: the Medicines and Poisons Act

Are peptides legal in Western Australia?

There is no one-word answer: two layers of law apply at once. Under the Therapeutic Goods Act 1989, 'peptide products are regulated as therapeutic goods in Australia': approved peptide medicines sit on the Australian Register of Therapeutic Goods (ARTG), while unapproved peptide products are goods never entered in it. A 'research use only' label changes none of that status, and the same advisory (TGA, 13 April 2026) adds that 'state and territory laws may impose additional controls on the sale, supply and possession of unapproved peptide products'. In Western Australia that layer is the Medicines and Poisons Act 2014.

Vendor pages print 'research use only' as though the words were shelter; the advisory answers in writing (TGA, 13 April 2026): 'Disclaimers that a product is for "research use only" does not make its supply lawful. These disclaimers alone do not: change a product's regulatory status; permit importation; or remove advertising or supply obligations.' No research-use or in-vitro exemption for private buyers appears in any of the instruments this page opened: the Poisons Standard, the Medicines and Poisons Act 2014, the Medicines and Poisons Regulations 2016 and the WA Health permit material. The label buys a private buyer nothing, and the only research pathway this page found is institutional.

Evidence limits

What will this page not tell you?

The discipline is the laboratory one this cluster lives by: a claim is only as good as the document behind it. In a 2015 study, 98 synthetic research peptides arrived with certificates stating at least 95.0% purity, and independent re-testing confirmed the specification for 43 (Verbeke et al., Journal of Pharmaceutical Analysis, 2015). Legal text gets the same treatment: quoted, dated, or left out.

How does a federal schedule become WA law?

A federal schedule becomes Western Australian law in four steps. First, the TGA classifies medicines and chemicals 'into Schedules according to the level of regulatory control over the availability of the medicine or chemical required to protect public health and safety' (TGA scheduling page). Second, they are published in the Poisons Standard — currently the Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, registered 28 May 2026. Third, a state gives the schedules legal effect — the Standard 'is given legal effect through State and Territory legislation' (TGA, Introduction to the Poisons Standard). Fourth, WA's reg 6 classifies each listed substance as a WA poison, Schedule by Schedule (Medicines and Poisons Regulations 2016).

Regulation 6 provides: 'Each substance, other than an exempt substance or nicotine, described in an item in the Table is classified as a poison included in the Schedule specified in that item'; the Table's Schedule 4 entry reads 'A substance listed in the current Poisons Standard Schedule 4'; and regulation 3 ties the phrase to section 3(1) of the Commonwealth Act. Change the federal instrument and the WA classification moves with it (version 00-t0-00, current from 1 July 2026).

WA runs two adoption tracks. The therapeutic-goods law — ARTG, advertising, import — arrives through the Therapeutic Goods Law Application Act 2024 (WA), proclaimed 30 August 2024, and WA Health states it covers 'persons conducting business in Western Australia, whether operating as a corporate entity or as a sole trader' (page last reviewed 4 September 2024). Poisons-and-scheduling controls travel the other track: the 2014 Act and Regulations.

What does the Medicines and Poisons Act 2014 do?

The Medicines and Poisons Act 2014 (WA) — Act No. 013 of 2014, assented 2 July 2014 — is Western Australia's law for the manufacture, supply, possession and use of medicines and poisons, with the Medicines and Poisons Regulations 2016 as subsidiary legislation. WA Health describes the pair as containing 'a number of key reforms for health practitioners and businesses handling medicines', replacing the ageing Poisons Act 1964 and Poisons Regulations 1965. Most provisions commenced 30 January 2017; the consolidation read here is version 00-l0-00, current from 26 September 2025 (legislation.wa.gov.au). Its definition of supply reaches online offers expressly (s 8).

Is there a research permit pathway in WA?

Yes, and it is institutional. Regulation 79 of the Medicines and Poisons Regulations 2016 defines a 'Research/ Education permit' as one 'to use specified poisons for the purpose of education or research on behalf of a specified school, university, government department or research organisation'. WA Health's licences-and-permits page, last reviewed 16 June 2026, describes purchase 'for education or research, such as at a school or university' and states the boundary: permits allow purchase from a licensed supplier and storage at listed premises, but 'do not allow resale and will be issued for a specified use'.

The application form's first listed purpose is 'In vitro research' — work in glassware, not bodies — then teaching and demonstration, and human and animal research, both requiring ethics-committee approval. The permit is no consumer pathway and creates no general research exemption: it is the state supervising a purchase, not waiving one.

Which peptide has a dated scheduling decision?

BPC-157. The TGA's final scheduling decision of November 2023 created a new Schedule 4 entry for BPC-157 with an Appendix D, clause 5 listing — the appendix for poisons whose possession without authority is illegal — implemented on 1 June 2024, the delegate citing 48 import referrals since 1 July 2022. The June 2026 Poisons Standard agrees: F2026L00633 carries BPC-157 in Schedule 4 and in Appendix D, clause 5 (instrument text checked 9 September 2026). One compound, its status read from two documents.

BPC-157 is a synthetic fragment of a protein found in human gastric juice. Its literature opens with a 1993 paper in the Journal of Physiology-Paris (Sikiric et al., 1993) and runs mostly through animals and cells: a 2011 Journal of Applied Physiology study tracked tendon outcomes in rats and cultured tendon cells (Chang et al., 2011). The BPC-157 research guide covers the record.

CJC-1295, ipamorelin and TB-500 carry the same Schedule 4 and Appendix D, clause 5 entries in the June 2026 instrument (checked 9 September 2026); the CJC-1295 and ipamorelin research guide covers that pair. Four others — semax, selank, MOTS-c and NAD+ — are not individually listed as of 9 September 2026; absence from a document is never a permission. The BPC-157 reference material we supply is freeze-dried and matched to its batch lab report; 'research grade' is a market category, not a legal one (what research grade actually means).

Is advertising a separate question?

Advertising is regulated apart from supply and apart from scheduling, under the therapeutic-goods advertising rules, and the TGA has aimed at the peptide market's main channel: 'Advertising or promoting unapproved peptide products, particularly through social media or influencer channels, is likely to breach Australian therapeutic goods advertising laws' (advisory, 13 April 2026). It is a separate rulebook, biting even where no supply ever happens. Anyone learning about these compounds from sponsored posts is reading what the regulator describes in those terms.

What happens when the rules are broken?

The TGA media release of 17 August 2026 records that breaches of the Therapeutic Goods Act 1989 carry civil and criminal penalties, so enforcement is real rather than theoretical. Those are Commonwealth consequences for Commonwealth breaches. Advertising is policed separately from supply: the therapeutic-goods advertising rules bite even where no supply ever happens. No penalty number appears on this page, from either jurisdiction: each figure sits in its own instrument, where its context is visible, and this page stays with the instrument rather than lifting the number out of it.

One honest absence belongs on the record: a September 2026 search pass found no WA-specific peptide prosecution, no Perth enforcement story and no WA Health peptide warning — an absence in a search, not proof of absence. Importing is its own federal question — what the TGA says about importing — and the logistics pages sit inside the hub's wider Perth peptides guide.

The Perth-side notes on this page come from our Perth-based research store, where every vial is matched to a lot and a lab report before dispatch. What the Act means for anyone's circumstances is a question for a lawyer, not a catalogue.